Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marilyn R. Cost
Development of a Vaginal Delivery Film Containing EFdA, a Novel Anti-Hiv Nucleoside Reverse Transcriptase Inhibitor
International Journal of Pharmaceutics
Pharmaceutical Science
Related publications
Synthesis and Anti-Hiv Activity of Some [Nucleoside Reverse Transcriptase Inhibitor]-C5′-Linker-[Integrase Inhibitor] Heterodimers as Inhibitors of HIV Replication
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Pharmaceutical, Clinical, and Resistance Information on Doravirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection
Drugs in Context
Molecular Medicine
Pharmacology
Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan
PLoS ONE
Multidisciplinary
Nucleoside Reverse Transcriptase Inhibitor Usage and the Incidence of Peripheral Neuropathy in HIV/AIDS Patients
Antiviral Chemistry and Chemotherapy
Medicine
Virology
Drug Discovery
Pharmacology
Identification of a 3-Aminoimidazo[1,2-A]pyridine Inhibitor of HIV-1 Reverse Transcriptase
Virology Journal
Virology
Infectious Diseases
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the NDihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
Mechanisms of Inhibition of HIV Replication by Non-Nucleoside Reverse Transcriptase Inhibitors
Virus Research
Cancer Research
Virology
Infectious Diseases
Nucleoside Reverse Transcriptase Inhibitors Prevent HIV Protease Inhibitor-Induced Atherosclerosis by Ubiquitination and Degradation of Protein Kinase C
American Journal of Physiology - Cell Physiology
Physiology
Cell Biology
